Paulson & Co 13F, Q1 2025
John Paulson · quarter ending 31 March 2025 · filed 15 May 2025 · SEC CIK 1035674
Common stock only: shares the fund reported owning at the quarter end, valued as filed.
Largest positions, Q1 2025
Weights are against the whole filed book. Changes are in shares held, against the Q4 2024 filing.
| Company | Ticker | Value | % of book | vs Q4 2024 |
|---|---|---|---|---|
| MADRIGAL PHARMACEUTICALS INC | MDGL | $695.43M | 39.8% | +3% shares |
| PERPETUA RESOURCES CORP | PPTA | $264.81M | 15.2% | unchanged |
| ACADIAN ASSET MANAGEMENT INC | AAMI | $231.45M | 13.3% | unchanged |
| BAUSCH HEALTH COS INC | BHC | $171.06M | 9.8% | unchanged |
| AGNICO EAGLE MINES LTD | AEM | $84.95M | 4.9% | unchanged |
| NOVAGOLD RES INC | NG | $79.54M | 4.5% | unchanged |
| THRYV HLDGS INC | THRY | $54.83M | 3.1% | unchanged |
| INTERNATIONAL TOWER HILL MIN | THM | $44.39M | 2.5% | +9% shares |
| HONEYWELL INTL INC | HONGBP | $42.35M | 2.4% | new |
| SEABRIDGE GOLD INC | SEA1EUR | $24.16M | 1.4% | unchanged |
| TRILOGY METALS INC NEW | TMQ | $22.21M | 1.3% | unchanged |
| EQUINOX GOLD CORP | EQX | $17.20M | 1.0% | unchanged |
| IAMGOLD CORP | IAG | $11.56M | 0.7% | unchanged |
| INTRA-CELLULAR THERAPIES INC | $2.84M | 0.2% | new |
What changed since Q4 2024
Against the Q4 2024 filing, Paulson & Co opened 2 new positions, added to 2, trimmed 0, left 10 unchanged and exited 1. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.
Other quarters
Source: SEC Form 13F-HR, accession 0001013594-25-000679, filed by PAULSON & CO. INC.. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.